Dr. Pal is an internationally recognized leader in the area of genitourinary cancers, including kidney, bladder, and prostate cancer. He is the co-director of City of Hope's Kidney Cancer Program, where he is also the head of the kidney and bladder cancer disease team. Dr. Pal entered college at the age of 13 and began medical school at the University of California Los Angeles (UCLA) at age 17. After completing his residency training at UCLA, Dr. Pal completed a fellowship program in medical oncology at City of Hope's comprehensive cancer center, where he has remained on faculty since 2009.
Dr. Pal sits on the editorial board for Kidney Cancer, and he is a reviewer for multiple journals, including The Lancet, The Journal of Clinical Oncology, The Journal of Urology, European Urology, and others. He has received grants from the National Institute of Health, the Comprehensive Cancer Network, SWOG Cancer Research Network, and multiple other leading entities in support of his research.